Clinical Gastroenterology and Hepatology

Article	Citations
Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease	406
Reply	314
Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care	215
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?	206
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	205
Simplifying ADR Reporting: A Worthy Goal, but the Devil is in the Details	202
An Unexpected Subepithelial Lesion: Catching the Diagnosis Earlier!	195
Reply	177
Gastric Emphysema With Hepatic Portal Venous Gas Secondary to Acute Gastric Mucosal Lesion	164
Editorial Board	158
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study	156
Attribution of Colonoscopy Risk Does Not FIT!	152
Exam 1: Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis	145
Table of Contents	143
Cover	139
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward	139
Issue Highlights	137
Elsewhere in the AGA Journals	134
Correction	130
Hepatic Artery Pseudoaneurysm After Whipple Procedure	129
FODMAPs in IBS: Revisiting Restriction	127
Blue Notes	126
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	116
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	109
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	108

Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	108
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling	107
Editorial Board	106
Front Cover	106
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	105
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease	103
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis	100
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicentre, Sham-controlled, Randomized Trial	99
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort	97
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial	94
Ambulatory Acute Kidney Injury in Patients with Cirrhosis is Common and Burdensome	93
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	91
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	91
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis	87
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	86
HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy	85
Reply	85
A Case of Pedunculated Esophageal Neuroendocrine Tumor G1	85
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI	85
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study	85
Assessment and Significance of Histologic Activity in Crohn’s Disease	84
Hyperbaric Oxygen Therapy Is Effective in the Treatment of Inflammatory and Fistulizing Pouch Complications	83
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	83
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis	83
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	83
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	82
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States	81
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	81
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability	81
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	80
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study	80
Long-term Effectiveness and Safety of Risankizumab in Patients with Crohn’s Disease	80
In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent	76
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy	76
An Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar Obstruction	75
AGA Clinical Practice Update on Endoscopic Management of Perforations in Gastrointestinal Tract: Expert Review	75
Update in the Treatment of the Complications of Cirrhosis	75
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	74
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis	74
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	74
PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMission	73
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States	72
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease	71
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	71
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis	70
Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study in South Korea	68
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States	68
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	67
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist	66
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study	65

Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy	65
Relationship Between Gastric Emptying Rate and Simultaneously Assessed Symptoms in Functional Dyspepsia	65
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	65
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study	64
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population	64
Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis	63
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion	63
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis	63
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study	62
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review	62
Information for Authors and Readers	61
Blue Notes	61
Editorial Board	60
Reply	60
Cover	60
Issue Highlights	59
Information for Authors and Readers	59
Reply	59
Reply	59
Reply	58
Transient Uterine Prolapse: A Rare Complication of Endoscopic Polypectomy	58
Information for Authors and Readers	58
Editorial Board	58
Direct Oral Anticoagulants in Budd-Chiari Syndrome: Need a Closer Look!	58
Table of Contents	58
Von Willebrand Factor Level Indicate Response to β-Blockers in Cirrhosis: Need a Closer Look!	57
Editorial Board	57
Cover	56
Health Policy Priorities for the Biden Administration	56
Editorial Board	56
Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons	55
Continuous Risk Score Predicts Waitlist and Post-transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes	55
Table of Contents	55
Unusual Presentation of a Crohn’s Disease Patient: Not Your Typical Flare	55
Multiple Negative Fecal Immunochemical Tests: Is Testing Really Better?	55
Reply	55
Skills or Pills: Randomized Trial Comparing Hypnotherapy to Medical Treatment in Children With Functional Nausea	55
Hurdles in ERCP Trials: Do We Need to Change the Diagnostic Criteria for Post-ERCP Pancreatitis?	54
Diet and Microbiome-Directed Therapy 2.0 for IBD	54
Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study)	54
Needle Track Seeding After Trans-gastric EUS-guided Tissue Sampling: Maybe Not as Rare as You Think	54
Environmental Toxins in Breast Milk and Risk of Early Onset Colorectal Cancer	53
Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease	53
Bowel Perforation by Intrauterine Device	52
Colon Volume by Computed Tomography and Scintigraphic Colonic Transit in Constipated Patients With or Without Redundant Colon	52
Long-Term Proton Pump Inhibitor Use: Review of Indications and Special Considerations	52
Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps	52
Reply	52
Close Observation of the Lateral Walls of the Oropharynx During Esophagogastroduodenoscopy	51
Incidence of and Risk Factors for Colorectal Strictures in Ulcerative Colitis: A Multicenter Study	51
Perianal Fistulizing Crohn’s Disease–Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus	51
Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial	51
Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis	50
Reply	50
Reply	50
Uptake of Colorectal Cancer Screening in 45 to 49 Year Olds: An Early-Inning View from the Endoscopy Suite	49
A Framework for Creating a FOAMed Organization in Gastroenterology: Lessons Learned from the Liver Fellow Network	49
Statins for Chronic Liver Disease and the Need for Randomized Controlled Trials	49
Foaming at the Varix: Sclerotherapy of Esophageal Varices via Intrahepatic Portal Vein Access	49
Exploring the Early Phase of Crohn’s Disease	48
Correction	48
Bouveret Syndrome Treated With Endoscopic Lithotripsy and Gallbladder Access via Cholecysto-duodenal Fistula	48
Continuing the Commitment to Diversity, Equity, and Inclusion Within AGA Journals	48
The New Kids on the Block: Emerging Complementary Colonoscopy Quality Metrics	48
Front Cover	48
Preoperative Hepatology and Primary Care Visits Improve Postoperative Outcomes in Patients With Cirrhosis Undergoing Surgery	47
Value of Ammonia Testing in Clinical Practice	47
Reply	47
Diverticulosis Is Associated With Internal Hemorrhoids on Colonoscopy: Possible Clues to Etiology	47
Personalized (N-of-1) Clinical Trials for Inflammatory Bowel Disease: Opportunities and Challenges	46
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma	46
Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey	46
Significance of Crypt Atypia in Barrett’s Esophagus: A Clinical, Molecular, and Outcome Study	45
Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome	45
Distinct Clinical Physiologic Phenotypes of Patients With Laryngeal Symptoms Referred for Reflux Evaluation	45
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis	45
Constrictive and Hypertrophic Strictures in Ileal Crohn’s Disease	45
Prolonged Gastrointestinal Manifestations After Recovery From COVID-19	45
Deficits in Geriatric Assessment Associate With Disease Activity and Burden in Older Patients With Inflammatory Bowel Disease	45
Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies	45

The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population	45
All-cause and Cause-specific Mortality in Achalasia: A Nationwide Matched Cohort Study	45
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis	44
Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease	44
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults	44
Reply	44
Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct	44
Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy	44
Acute-onset Type 1 Diabetes Mellitus and Pancreatic Atrophy Caused by an Immune Checkpoint Inhibitor	44
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update	44
Population-based Screening for Hereditary Colorectal Cancer Variants in Japan	43
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study	43
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease	42
Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease	42
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network	42
Harm-to-Benefit Ratio of Fecal Immunochemical Test–Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations	42
Birth Cohort Colorectal Cancer (CRC): Implications for Research and Practice	42
Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring	42
Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals	42
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion	42
An Unusual Complication of Endoscopic Ultrasound-guided Transgastric Liver Biopsy	41
The Severity of Reduced Esophageal Distensibility Parallels Eosinophilic Esophagitis Disease Duration	41
Gastroparesis and Chronic Pancreatitis: Are They Truly Related?	41
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis	41
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis	41
Primary Sclerosing Cholangitis–Associated Pouchitis: A Distinct Clinical Phenotype	41
North American Expert Consensus on the Post-procedural Care of Patients After Per-oral Endoscopic Myotomy Using a Delphi Process	41
Elsewhere in the AGA Journals	41
Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens	41
Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis	40
Reply	40
Supplementing Dietary Fibers With a Low FODMAP Diet in Irritable Bowel Syndrome: A Randomized Controlled Crossover Trial	40
Table of Contents	40
Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate	40
Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease	40
Reply	40
Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease	39
Reply	39
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study	39
Reply	39
Stratifying Risks of Ileal Pouch Outcomes	39
Bleeding Gastric Teratoma on Adult Patient	39
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis	38
To Stop or Not to Stop? Predicting Relapse After Anti-TNF Cessation in Patients With Crohn’s Disease	38
Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn’s Disease	38
Reply	38
Letter Response to: Hernandez-Rocha C et al, Clin Gastroenterol Hepatol 2024	38
Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma With Varices Using Red Dichromatic Imaging	38
Lymphangioma in a Child Managed With Debulking Surgery	38
Reply	38
Porcelain Gallbladder	38
Adult-Onset Fontan Circuit Failure: A Rare Cause of Protein-Losing Enteropathy	38
Reply	37
Editorial Board	37
Prediction of Postoperative Recurrence in Crohn’s Disease: Where Do We Go From Here?	37
Information for Authors and Readers	37
Editorial Board	37
Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities	37
Blue Notes	37
Front Cover	37
Blue Notes	37
Editorial Board	37
Repeating Ultrasound for Hepatocellular Carcinoma Detection in Case of Inadequate Liver Visualization: A Matter of Expertise	36
Diffuse Large B-Cell Duodenal Lymphoma Presenting With Obstruction and Pneumatosis	36
Preparing the Next Generation of Gastroenterologists to Tackle Climate Change	36
Approach to Dietary Restriction in Irritable Bowel Syndrome	36
Diagnosis of Retrograde Cricopharyngeus Dysfunction Using High Resolution Impedance Manometry and Comparison With Control Subjects	36
Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy With Inflammatory Bowel Disease: Stop the Disease, Not the Drug!	36
Decreasing Case Fatality Rates for Patients With Cirrhosis Infected With SARS-CoV-2: A National COVID Cohort Collaborative Study	36
Elsewhere in the AGA Journals	36
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era	35
Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases	35
Nature and Nurture in Familial Aggregation of Steatotic Liver Disease	35
Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis	35
Symptom Classes in Decompensated Liver Disease	35
Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance	35
Reply	35
Reply	35
Underestimation of Cirrhosis-Related Mortality in the Medicare Eligible Population, 1999–2018	34
The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude	34
Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases	34
Reply	34
Dietary Fiber is Associated With Decreased Risk of Gastroesophageal Reflux Symptoms	34
Crafting a Therapeutic Pyramid for Eosinophilic Esophagitis in the Age of Biologics	34
Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy	34
Clinical, Pathology, Genetic, and Molecular Features of Colorectal Tumors in Adolescents and Adults 25 Years or Younger	34
Abdomino-anal Dyscoordination in Defecatory Disorders	34
Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study	34
Patient Navigation Increases Linkage to Care and Receipt of Direct-acting Antiviral Therapy in Patients with Hepatitis C	34
Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet	33
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease	33
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice	33
Baseline Hepatitis B Virus Surface Antigen Titers in Childhood Predict the Risk of Advanced Liver Fibrosis in Adulthood	33
Linked-Color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial	33
Perceptions, Definitions, and Therapeutic Interventions for Occasional Constipation: A Rome Working Group Consensus Document	33